Accurate • Fast • Inexpensive • Easy to Perform • Single Visit


Preventing, detecting, and treating tuberculosis is a significant public health issue. The World Health Organization estimates that more than one-third of the world's population is infected with tuberculosis (TB), and millions die each year. Current screening and testing methods are slow, complex, and insufficient to address the problem.

nanoRETE is developing the next generation of TB screening tests, solving the problems of current tests while advancing the method to single point-of-care. Our goal is to successfully replace today’s sub-optimal screening tests with a more accurate and efficient test at an affordable price.